Found 676 matching trials
SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients PHASE2 Open label multicentric randomized phase II trial, using high throughput ge...
Show More Location
Centre Hospitalier Henri Duffau
Learn More & Join Trial
Nasal Allergen Challenge Test as a Method to Detect Clinical Reactivity Against Birch Pollen NA Clinical efficacy and tolerability for allergen specific immunotherapy (AIT...
Show More Location
Karolinska University Hospital
Learn More & Join Trial
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy PHASE2 This study is a multicenter, prospective, randomized phase II trial aimed a...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors PHASE2 Drugs called checkpoint inhibitors help the immune system fight cancer. Whe...
Show More Status
Active Not Recruiting
Location
Hartford Healthcare
Learn More & Join Trial
A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKI PHASE3 This study is a multicenter, open-label, randomized controlled trial that e...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC PHASE2 This study compares the efficacy of neoadjuvant low-dose radiotherapy plus ...
Show More Location
Multiple Locations
Learn More & Join Trial
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive PHASE1 Background:
The National Cancer Institute (NCI) Surgery Branch has develop...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease) PHASE2 This study is a prospective cohort clinical trial that aims to investigate ...
Show More Location
The Affiliated Suzhou Hospital of Nanjing Medical University
Learn More & Join Trial
Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC. PHASE2 This study is a multicenter, prospective, randomized, double-arm, Phase II ...
Show More Location
Dept. of Colorectal Surgery, Sun Yat-sen University Cancer Center. Yuexiu District, Dongfeng East Road 651
Learn More & Join Trial
Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer PHASE3 This is a randomized, controlled, multicenter clinical study that enrolled ...
Show More Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial